Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(NASDAQ:RGC) Insiders Percentage and they have not stop buying
In investing, it is always worth while to findout who are the majority shareholders of the company. Understanding of business ownership strucutre is vital as it determines who is in control of the company and its direction. Moreso, having a large number of shares would either benefit or loses most when the stock price moves.
Data shows that insiders recently bought shares in the company and they were rewarded after market cap rose US$64m last week.
[For Image of Chart/Graph, kindly refer to the link at end of post]
Small companies that are not very actively traded often, thus lack institutional investors. It is more common to see insitutional investors in larger companies instead.
There are multiple explanations for why institutions don't own a stock. The most common is that the company is too small relative to funds under management, so the institution does not bother to look closely at the company. Alternatively, there might be something about the company that has kept institutional investors away.
Hedge funds don't have many shares in Regencell Bioscience Holdings. With a 81% stake, CEO Yat-Gai Au is the largest shareholder. It's usually considered a good sign when insiders own a significant number of shares in the company, and in this case, it’s glad to see a company insider with such skin in the game. In comparison, the second and third largest shareholders hold about 7.6% and 0.1% of the stock.
With a 11% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Regencell Bioscience Holdings. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
With a stake of 7.6%, private equity firms could influence the Regencell Bioscience Holdings board. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.
[https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgc/regencell-bioscience-holdings/news/regencell-bioscience-holdings-limited-nasdaqrgc-insiders-hav]
MindMed - 18-MC Trial - Connecting the Dots to J&J - Updated & Revised
$MMEDF -> $MNMD
A Study to Assess 18-Methoxycoronaridine
https://www.clinicaltrials.gov/ct2/show/NCT04292197?lead=Mind+Medicine%2C+Inc.&lead_ex=Y&draw=2&rank=1
The current contact for this trial is listed as:
Rob Barrow... he replaced the contacts below who were originally listed on the Trial Data when this PR dropped on Feb. 2, 2021... which makes sense since he is the Business Development Officer:
https://www.prnewswire.com/news-releases/mindmed-streamlines-leadership-with-further-emphasis-on-integrating-psychedelic-drug-development-with-digital-medicines-and-therapeutics-301219840.html
---
The ORIGINAL contacts on this trial work for Janssen Pharmaceutical Companies were:
Jason Summa - https://www.linkedin.com/in/jasonsumma/Jamie Freedman - https://www.linkedin.com/in/jamie-freedman-0543104/
You can proof this by looking at the revision history of the Trial... Look at Version 5 of the document.
https://www.clinicaltrials.gov/ct2/history/NCT04292197?V_5=View#StudyPageTop
Both of these folks are tied to Johnson & Johnson via Janssen... I don't think that is a coincidence.
They are working with Linear Clinical Research Ltd in Australia / Perth. According to the website:
Australian (TGA) clinical trial start-ups are typically 4-6 months faster than US (FDA) trials. Better still, they’re much cheaper – often a third of the cost and exceptional quality.
No IND required
Fast-tracked approvals
Generous R&D refunds
Excellent health system Access to patient databases
Data accepted by FDA, EMA, CFDA & PDMA
---
Looks like to me they will fast track in Australia - then partner with J&J if successful.
MindMed To Commence Trading on Nasdaq - Uplisting from OTC
https://www.prnewswire.com/news-releases/mindmed-to-commence-trading-on-nasdaq-301275575.html
Mind Medicine (MindMed) Inc.
Apr 23, 2021, 07:30 ET
NEW YORK, April 23, 2021 /PRNewswire/ -- MindMed (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been approved for listing on The Nasdaq Capital Market ("Nasdaq"). Trading is expected to begin on Tuesday, April 27, 2021, under the symbol "MNMD" on the Nasdaq. MindMed will retain its listing on the Neo Exchange Inc. under the symbol "MMED" and the Company's subordinate voting shares will continue to trade on the OTCQB under the symbol "MMEDF" until trading on the Nasdaq commences.
"The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company," said J.R. Rahn, CEO and Co-Founder of MindMed. "We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness."
About MindMed
MindMed is a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. The MindMed executive team brings extensive biopharmaceutical experience to MindMed's approach to developing the next generation of psychedelic-inspired medicines and therapies.
MindMed trades on the Canadian exchange NEO under the symbol MMED and in Germany under the symbol MMQ. MindMed will commence trading on the Nasdaq under the symbol MNMD effective April 27, 2021; until then the Company will continue to trade in the United States under the symbol MMEDF on the OTCQB.
looks like they are running away without me...stuck in NOK with a huge position but still have good feeling longterm...-12% on that ...holding..
CSV,SCI,STON still in...
Who is still here ?
We have to cleanup that mess in the ibox..lol
Long time not here..sorry , had better things to do !
PSEC & ORC on watchlist again , rebuy soon !
DIVI's longterm...
STON half out holding the rest ! Nice ride from 70 cent to 3$+
StoneMor Inc. Announces Compliance With NYSE Listing Standards
https://finance.yahoo.com/news/stonemor-inc-announces-compliance-nyse-215800604.html
https://www.sec.gov/Archives/edgar/data/1753886/000156459020058269/ston-8k_20201223.htm
This ETF Yields 10% and Curs You a Check Every Month:
https://dailyinvestingadvice.com/this-etf-yields-10-and-cuts-you-a-check-each-month/
Dividend Stocks Between $10 - $20 over the next Week
- #stockstowatch #stockmarket #dividend
https://www.transparenttraders.me/2019/06/dividend-stocks-between-10-20-over-next.html
SNMX $0.71 >>>> Financial Results: SNMX MY NEXT 1000% TURN AROUND TICKET
Commercial revenues increased 24% to $2.8 million in the second quarter ended June 30, 2017. For the six months ended June 30, 2017, commercial revenues increased 25% to $5.5 million. These improvements primarily resulted from higher direct sales of flavor ingredients to flavor houses and higher royalties from sweet taste boosting ingredients
Financial Outlook:
Senomyx ended the second quarter 2017 with no debt and $11.2 million in cash, an increase of $1.1 million during the second quarter. In addition, the Company is scheduled to receive $14.0 million in committed development funding in the future.
For the third quarter of 2017, the Company expects:
Revenues to be at least $4.7 million, of which at least $2.9 million are commercial revenues; and
Net loss not to exceed $3.2 million or $0.07 per share
Looking for a reversal on the OXISD chart
September 2017 Dividend Stock Watch List
http://www.stocksmarketnews.com/september-2017-dividend-stock-watch-list/
AT&T (T): Yes, they are back on the dividend stock watch list. How could they not be? Their stock price has plummeted from trading at $ 38.35 on August 10th, down to $ 35.59 over the September 8th weekend, a drop of 7.2% in that short, one-month time span. They have a dividend increase coming up in November (or some time in the 4th quarter), which (more than likely) will be around that 2% growth rate that they have had. At this current price, with a current dividend of $ 1.96 per year, their yield is a wonderful 5.51% and is easily two full percentage points higher than my average yield on my portfolio
Delta Airlines (DAL): I purchased DAL back in mid-August at a price point of approximately $ 50 per share. However, they now trade at $ 47.45 or a 5.1% decline since my entry price. We know I usually have a rule that if I bought it at “X” and if it drops 5%, why wouldn’t I now buy it at “Y” if the fundamentals didn’t change.
Hormel (HRL): HRL is down 9.2% this year and is considered one of the longest dividend aristocrats out there. They have a dividend growth streak of over 50 years and this year they increased their dividend a whopping 17%. Their forward yield is $ 0.68 per share and at a share price of $ 31.60, this equates to a yield of 2.15%
863% GAIN (so far) if you took my advice on 11/18/16. Would be a shame if none of you took my advice. :)
BUT! There's still plenty of time for several HUNDRED PERCENT returns from $1.06.
News Out TODAY for $OWCP, who is a Cannabis Medicine/Biotech ready for launch!
Breakdown/Highlights of Today's BIG PR:
http://ownthefloat.com/index.php/2017/04/04/owcp-april-4th-8k-highlights-breakdown/
Official PR from PRnewswire:
http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-announces-world-wide-expression-of-interest-in-its-cannabis-based-topical-cream-for-treatment-of-psoriasis-and-other-skin-disorders-618344633.html
The coca cola company, Walmart store, are two of the stocks market's gem that must be included in any big portfolio.
Coca cola
The company has 124 years of history in which it has never missed a dividend payment. Not only has it paid a dividend each quarter since 1920, but it has also increased dividends in each of the last 54 years, making KO stock a “dividend king,” a distinction earned by those companies which have raised dividends for at least 50 straight years.
The company increased its quarterly dividend in February by six percent to $0.35 per share. At today’s price, KO stock has an annual dividend yield of 3.28%. In the past 10 years, the company’s quarterly dividend payment has more than doubled.
Walmart stores
Another important reason to make Wal-Mart a part of your top-paying dividend stock portfolio is that the company is recession-proof due to its unrivaled power of getting the best prices from its suppliers and selling products which are consumers are unlikely to stop buying in the event of a spending cut. WMT stock has proven over many recessions that it can beat the market by a big margin, as consumers turn to discount retailers on the first sign of recession.
Get in on the ground level of OWCP
Read some of the DD at www.OwnTheFloat.com
FGP trading near 52 week low. Has a 25.94% dividend yield!
TIS...$34.86...All-time closing high>>>Annual Dividend/Yield>>>$1.40/4.18%
Summer 2016 is finally here
Hope ya still are, I'm a friend
FYI
I didn't know this was coming.
The NYSE and NASDAQ will no longer accept stop and good-till-cancelled orders come February 26.
Hi friends,
i am still living...
Just wanted to send a "living Signal"...hope you are all well !
b
NVLX - 7/16/14 price about 27 cents. Nuvilex has a drug delivery technology which is innovative, effective, technologically advanced, causes less side effects, and is flexible across a broad spectrum of ailments. Nuvilex has Dr. Von Hoff and Dr. Matthias Löhr on their team, two leading pancreatic/tumor cancer specialists (google them). Nuvilex has the licensing agreements to patented technology (cell in a box). They have everything ready to capture major segments of this market (pancreatic cancer, pain, tumors, diabetes, etc). Investors right now are just early to the party, people are learning about Nuvilex as we speak...after pre-clinical (Aug 2014) and start of Phase 2b clinical (early 2015), the real show will start in my opinion.
IFON alot of great things going on for 2014
Atlantic Power Corp declares C$0.03333 dividend
Atlantic Power Corporation (AT) declares C$0.03333/share monthly dividend.
Forward yield 11.38%
Payable Jan 31; for shareholders of record Dec. 31; ex-div Dec. 27.
AT book value > 5$ ... pays 10% dividend, monthly payout
Canadian utility company
PTSC link back to chart !
sick!>>***Digital & Spirit - Phantom Force (Fracture's Astrophonica edit)
Stray - When it Rains (Blu Mar Ten Music)
yoyoyo now hear this!!!~>FVKINGGG H U G E E E E!!!!!!!!!
TSLA two tier 1 comments: Merrill/BofA out cautioning clients - Caution: Oversize Load implied in current share price. They are UP-rated
TSLA is a momentum driven stock, but we believe financial theory will ultimately prevail, shares return to $37 PO - Merrill
'Tesla would need to sell 2-3X our optimistic 2013e volume in 2014 to justify current mkt levels,' Merrill
'..We estimate that ex. Zero Emission & other regulatory credits, TSLA’s 1Q13 gross margin was roughly 2.4%,' Merrill
***GROC***@LOW'DD DAA BOAT MANEEEE~BTW WHEN U GOING TO BREAK OUT THAT JJUNGLE FROM 94'?>>> iTS BACK!!!
LOVE U BRO! WEEEEE
Bwaller you da man !
I am still here...not much but lurking...
Dont worry !
Greetings to NITWIT aswell looks like he is missing me
BTW: cant post on youdaman board...no subbi !
2013 PROMO====BEAT$$$$(V.I.P.)~~~~> http://vimeo.com/65114526
STI Conductus 2G HTS Wire Pilot Production Equipment Now Operational
Febr 22nd 2013
- Shipped first wire completely fabricated in STI's Austin facility -
- Increased customer requests for Conductus wire -
- Met product requirements for low temperature application -
AUSTIN, Texas, Feb. 21, 2013 (GLOBE NEWSWIRE) -- Superconductor Technologies Inc. ("STI") (Nasdaq:SCON), a world leader in the development and production of high temperature superconducting (HTS) materials and associated technologies, has successfully completed the installation of its equipment suite required for production of Conductus® 2G HTS wire at its Advanced Manufacturing Center of Excellence facility in Austin during the fourth quarter of 2012 as planned. At this time all 2G HTS wire pilot production equipment is operational and in various stages of process implementation.
All three machines required for production of Conductus 2G HTS wire are operational and achieving expected functional milestones.
The IBAD system, delivered in April 2012, has completed process implementation. It is now being used in full production and achieving record results as of January 2013.
The SDP system, delivered in November 2012, has also completed initial process implementation. The initial pilot production runs of 50 meter lengths and 10 centimeter widths were completed in early February 2013.
The RCE-CDR system, delivered in December 2012, has been installed with first process run completed in February 2013.
"We continue to increase our customer activities, which are reflected by the expanding requests for Conductus wire," said Jeff Quiram, STI's president and chief executive officer. "At this time, the current customer requests will consume all available supply of Conductus wire that we can produce through the first few quarters of 2013. Recently we shipped the first Conductus wire completely fabricated in our Austin facility, and it is being tested for a superconducting motor application. In January, we also achieved product requirements for a low temperature, high infield superconducting magnet application by achieving greater than 2500 amps per centimeter at 4 Kelvins. In addition, we passed testing in magnetic field strengths greater than 14 Tesla."
"As we have discussed previously, we continue to focus on providing longer lengths of wire for our demonstration cable partner," Quiram continued. "We believe that these efforts will be greatly aided by the turn up of our new RCE-CDR system in Austin. We remain committed to providing the wire as quickly as possible to complete that project."
SCON - Bard Associates new 1.2mln stock position - dec 31st inst holdings.
PSN.to 1.25 entry
110mln market cap here, down from 1.2bln or 16$ a share three months ago
and dividend used to be 0.09$ per quarter
Happy new year to you and yours B!
Followers
|
167
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
10237
|
Created
|
02/03/08
|
Type
|
Free
|
Moderator peewee | |||
Assistants kgoodrich read_this_n0w Bull Trader dav1234 JimsZ |
This board was created displaying/reporting stocks which have good fundamentals and meet the requirements for a longterm investment.
For discussing about each individual stock please refer to the corresponding board.
The main goal is to minimize the investment risk, even tho the stockmarket is influenced by many factors which we cannot control.
Strict rules for confirming a company will be extended and observed.
We have lately added some other sections like Promising Biotechs, High Yield Dividend Stocks and Chapter 11- P(Q)LI.
Economic Calendar SEC Filing Calendar NASDAQ - pre market NASDAQ - after market NASDAQ - Trade Halts FDA
Current Mod Team
Useful Links
Tips for successful longterm investing
http://www.investopedia.com/articles/00/082100.asp
The Magic Box / Learn about Setups (Thanks KEN ! This is really good to start with ! )
http://stocktraderschat.com/tradingforum/seasonality_subscribe9.php#p7GPc1_9
Short Interest Data
http://shortsqueeze.com/
Institutional buys adds and sells
http://www.mffais.com
Insider Trading
http://www.insidercow.com/
Dividend Detective
http://www.dividenddetective.com/
SEC filings
http://www.sec.gov/edgar/searchedgar/companysearch.html
Death spiral financing definitions.... 3 Versions (be very careful with stocks which have convertible debentures)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43580688
NASDAQ OMX, NASDAQ Options Market and NASDAQ OMX PHLX Holiday Schedule
http://www.nasdaqtrader.com/Trader.aspx?id=Calendar
10 Ways To Spot A Pump-And-Dump Scam
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=49407137
Khan Academy (Educational Videos)
http://www.youtube.com/user/khanacademy
http://www.khanacademy.org/
Lowtrades Youtube Channel
http://www.youtube.com/user/lowtrade
None at the Moment........
Promising Biotechs
http://finviz.com/screener.ashx?v=111&f=ind_biotechnology
Mike Havrilla-Blog @ Seeking Alpha
ANX-530 (vinorelbine emulsion)
***
***
View CEL-SCI Presentation (NOV. 09)
***
Excellarate Clinical Development Program Presentation (OCT. 09)
***
Cyclacel Pharmaceuticals, Inc.
***
Dynavax Technologies Corporation
***
***
***
***
Keryx Biopharmaceuticals, Inc.
***
***
Corporate Presentation (NOV. 09)
***
Spectrum Pharmaceuticals, Inc.
***
***
***
***
***
STON / StoneMor Partners L.P.
Website: http://www.stonemor.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=15249
Latest Dividend: $0.5550 (quarterly)
WRI / Weingarten Realty Investors
Website: http://www.weingarten.com/
IHUB Board: n/a
Latest Dividend: http://phx.corporate-ir.net/phoenix.zhtml?c=103077&p=irol-dividends
PWE / Penn West Energy Trust
Website: http://www.pennwest.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=7357
Latest Dividend: variable (monthly)
ACAS / American Capital Ltd. / Alerted on 15. April 2009 2.62$ (0815ax)
Website: http://www.americancapital.com/ & http://www.europeancapital.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=7980
Latest Dividend: http://www.americancapital.com/investor_relations/dividends/dividends.html
SSW / Seaspan Corporation
Website: http://www.seaspancorp.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=11181
Latest Dividend: http://www.seaspancorp.com/investors/distributions.cfm
GSL / Global Ship Lease
Website: http://www.globalshiplease.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=15380
Latest Dividend: In connection with the waiver agreement with the lenders under our credit facility, GSL has suspended the payment of dividends until the end of the waiver period or another amendment to the credit facility is put into place. At that time, the dividend policy will be reviewed by the Board of Directors.
http://www.globalshiplease.com/dividends.php?yr=2008
CMED / China Medical Technologies
Website: http://www.chinameditech.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=5494
Latest Dividend: http://ir.chinameditech.com/phoenix.zhtml?c=192852&p=irol-dividends
AOD / Alpine Total Dynamic Dividend Fund / Alerted on 03. December 2009 (investorswisdom)
Website: http://www.alpinecef.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=15993
Latest Dividend: http://www.alpinecef.com/aod-distributions.html
RSO / Resource Capital Corp / Alerted on 24. December 2009 (dav1234)
Website: http://www.resourcecapitalcorp.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=16643
Latest Dividend: http://phx.corporate-ir.net/phoenix.zhtml?c=192004&p=irol-dividends
PVX / Provident Energy Trust
Website: http://www.providentenergy.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=5594
Latest Dividend: http://www.providentenergy.com/investor/distributions/currentdistributions.cfm & http://www.providentenergy.com/investor/distributions/historicaldistributions.cfm
PSEC / Prospect Capital Corp.
Website: http://patcapfunding.com/
IHUB Board: http://investorshub.advfn.com/boards/board.aspx?board_id=18134
Latest Dividend: http://www.snl.com/irweblinkx/divs.aspx?iid=4092630
The other divi stocks i want to mention...i put them up soon...just wanted to post because one just runs away.. hehe
http://stockcharts.com/scripts/php/candleglance.php?NGLS,WPZ,MWE,LINE,KED,AINV|B
Overview Biotechnology ==> <== Overview Biotechnology
Chapter 11 - P(Q)LI ...formerly NASDAQ, NYSE, AMEX
www.sec.gov/investor/pubs/bankrupt.htm
Great other IHUB-Boards
Disclaimer:
Please discuss the details of each stock on the corresponding discussion board.
Invest on your own risk and responsibility !
Buy/Sell/Hold on your own , always do your own DD !
Date | Federal Holidays | |
Friday, January 01, 2010 | New Year's Day | EDGAR & SEC Closed |
Monday, January 18, 2010 | Martin Luther King, Jr. Day | EDGAR & SEC Closed |
Monday, February 15, 2010 | Presidents' Day | EDGAR & SEC Closed |
Monday, May 31, 2010 | Memorial Day | EDGAR & SEC Closed |
Monday, July 05, 2010 | Independence Day | EDGAR & SEC Closed |
Monday, September 06, 2010 | Labor Day | EDGAR & SEC Closed |
Monday, October 11, 2010 | Columbus Day | EDGAR & SEC Closed |
Thursday, November 11, 2010 | Veteran's Day | EDGAR & SEC Closed |
Thursday, November 25, 2010 | Thanksgiving Day | EDGAR & SEC Closed |
Friday, December 24, 2010 | Christmas Day | EDGAR & SEC Closed |
Posts Today
|
0
|
Posts (Total)
|
10237
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |